Survival analysis and associated factors of acquired immune deficiency syndrome patients under antiretroviral therapy in He'nan Province during 2005 to 2015
10.3760/cma.j.issn.1000-6680.2018.02.003
- VernacularTitle:河南省2005至2015年抗病毒治疗艾滋病患者生存状况及影响因素分析
- Author:
Yan SUN
1
;
Qingxia ZHAO
;
Xuan YANG
;
Chunli LIU
;
Xue ZHANG
;
Chaofeng LI
;
Zhaoyun CHEN
Author Information
1. 450015,郑州市第六人民医院感染二科
- Keywords:
Acquired immune deficiency syndrome;
Antiviral therapy;
Survival time;
Influencing factors
- From:
Chinese Journal of Infectious Diseases
2018;36(2):74-77
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the survival status and the prognostic factors of aquired immune deficiency syndrome (AIDS) patients under the highly active antiretroviral therapy (HAART) in He'nan Province.Methods Survival data of AIDS patients were collected from the National HAART reporting system between 2005 and 2015,and analyzed using SPSS 23.0 software.Results A total of 38 143 AIDS cases were enrolled in this study.The cumulative survival rate of patients under antiretroviral therapy after 1-5 years were 95％,91％,89％,86％ and 85％,respectively.The cumulative death cases were 5 704 and the total mortality was 3.68/100 person years (5 704/155 060 person years).A total of 1 975 cases died within a year with a percentage of 34.62％.Cox proportional hazard regression model analysis indicated that the hazard ratioc (HR [95％CI]) of death in patients with age of 40-49 years,50-59 yrears,60-69 yrears and ≥70 years groups compared to those with age ＜30 years group were 1.49 (1.22-1.80),1.88 (1.55-2.28),2.82 (2.32 3.42) and 4.60 (3.75-5.65),respectively.The HR (95％ CI) of death in patients with CD4 T cell counts ＜50 cells/μL,50-199 cells/μL,200-349 cells/μL groups compared to those of ≥350 cells/μL group were 3.28 (2.98-3.61),2.30 (2.09-2.53) and 1.39 (1.25-1.54),respectively.Male (HR-1.35,95％CI:1.28-1.42) and not switching to second line therapy (HR=4.41,95％CI:4.12-4.73) were the risk factors of death.Compared to sex transmission,blood transmission was the risk factors of death in AIDS patients.Conclusions The initiation of early HAART and timely switching to second line therapy for AIDS patients are key to prolong the survival time and to reduce AIDS related death.
